Plunkett Research Online: Proteo, Inc.

PROTEO, INC. (PTEO:PINX) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Proteo Inc operates as a clinical stage drug development company which engages in the development of anti-inflammatory treatments for rare diseases with unmet needs. It develops, promotes and market pharmaceuticals and other biotech products. The company is engaged in the development of pharmaceutic.....



Proteo, Inc.
Ticker: PTEO
Exchange: PINX
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 949 253-4616
Fax:
Address: 2102 Business Center Drive
Irvine, CA 92612 United States

Types Of Business
Industry Ranks

Industry NAICS code:

Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing
ContactsDescription
Birge BargmannCEO/CEO, Subsidiary/CFO/CFO, Subsidiary/Director/President
Hartmut WeigeltDirector
See More
Proteo Inc operates as a clinical stage drug development company which engages in the development of anti-inflammatory treatments for rare diseases with unmet needs. It develops, promotes and market pharmaceuticals and other biotech products. The company is engaged in the development of pharmaceutic.....See More See More

Auditor: SQUAR MILNER LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
201720162015201420132012
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and AffiliatesTop Salaries
Other ThoughtsCorporate Culture

Apparent Female Officers or Directors: